Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm
Clinical trial NCT03216473 · COMPLETED
Trial details
- NCT number
- NCT03216473
- Sponsor
- Medy-Tox
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-25
- Primary completion
- 2017-03-17
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.